JP2014502985A5 - - Google Patents

Download PDF

Info

Publication number
JP2014502985A5
JP2014502985A5 JP2013549807A JP2013549807A JP2014502985A5 JP 2014502985 A5 JP2014502985 A5 JP 2014502985A5 JP 2013549807 A JP2013549807 A JP 2013549807A JP 2013549807 A JP2013549807 A JP 2013549807A JP 2014502985 A5 JP2014502985 A5 JP 2014502985A5
Authority
JP
Japan
Prior art keywords
ethoxy
glp
compound
amino
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013549807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014502985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050785 external-priority patent/WO2012098188A1/en
Publication of JP2014502985A publication Critical patent/JP2014502985A/ja
Publication of JP2014502985A5 publication Critical patent/JP2014502985A5/ja
Withdrawn legal-status Critical Current

Links

JP2013549807A 2011-01-19 2012-01-19 Glp−1粒子および組成物 Withdrawn JP2014502985A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11151456 2011-01-19
EP11151456.8 2011-01-19
US201161436804P 2011-01-27 2011-01-27
US61/436,804 2011-01-27
PCT/EP2012/050785 WO2012098188A1 (en) 2011-01-19 2012-01-19 Glp-1 particles and compositions

Publications (2)

Publication Number Publication Date
JP2014502985A JP2014502985A (ja) 2014-02-06
JP2014502985A5 true JP2014502985A5 (enExample) 2015-03-12

Family

ID=43899633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013549807A Withdrawn JP2014502985A (ja) 2011-01-19 2012-01-19 Glp−1粒子および組成物

Country Status (5)

Country Link
US (1) US20140004198A1 (enExample)
EP (1) EP2665470A1 (enExample)
JP (1) JP2014502985A (enExample)
CN (1) CN103298456A (enExample)
WO (1) WO2012098188A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055735B (zh) * 2013-03-22 2016-08-03 深圳翰宇药业股份有限公司 一种萨摩鲁泰的脂质体及其制备方法
CN106132985B (zh) * 2014-04-07 2020-10-13 诺和诺德股份有限公司 双酰化glp-1化合物
ES2929218T3 (es) 2015-01-12 2022-11-28 Enteris Biopharma Inc Formas farmacéuticas orales sólidas
WO2017025990A1 (en) * 2015-08-13 2017-02-16 Sun Pharma Advanced Research Company Limited Long acting liraglutide compositions
CN109195622A (zh) * 2016-03-01 2019-01-11 深圳翰宇药业股份有限公司 一种药物组合物及其制备方法
US20190105268A1 (en) * 2016-03-31 2019-04-11 Sun Pharma Advanced Research Company Limited Viscoelastic Gel of Liraglutide Adapted for Once-Weekly or Once Bi-Weekly Administration
EP3474820B1 (en) 2017-08-24 2024-02-07 Novo Nordisk A/S Glp-1 compositions and uses thereof
CN115484935A (zh) * 2020-02-14 2022-12-16 G2G生物公司 包括含有glp-1类似物或其药学上可接受的盐的缓释微球的药物组合物
KR102253318B1 (ko) * 2020-06-02 2021-05-18 (주)위바이오트리 금속 상 변환 화합물 및 이의 제조 방법
CN111888334B (zh) * 2020-06-28 2022-03-18 苏州天微肽生物医药科技有限公司 一种利拉鲁肽微球缓释剂及其制备方法和应用
CN115887351B (zh) * 2023-01-03 2023-05-05 中科微针(北京)科技有限公司 一种glp-1受体激动剂类药物微针组合物、由其制备得到的微针及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7531094A (en) * 1993-08-24 1995-03-21 Novo Nordisk A/S Protracted glp-1
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
ES2283025T3 (es) 1996-08-30 2007-10-16 Novo Nordisk A/S Derivados de glp-1.1.
US6451762B1 (en) 1997-10-24 2002-09-17 Novo Nordisk A/S Aggregates of human insulin derivatives
EP1542712A2 (en) 2001-06-01 2005-06-22 Eli Lilly And Company Glp-1 formulations with protracted time action
US7101843B2 (en) * 2001-08-23 2006-09-05 Eli Lilly And Company Glucagon-like peptide-1 analogs
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
EP2021014A1 (en) * 2006-05-26 2009-02-11 Brystol-Myers Squibb Company Sustained release glp-1 receptor modulators
KR100805208B1 (ko) * 2007-03-27 2008-02-21 주식회사 펩트론 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
CN104000779A (zh) * 2007-04-23 2014-08-27 精达制药公司 促胰岛素释放肽的混悬制剂及其应用

Similar Documents

Publication Publication Date Title
JP2014502985A5 (enExample)
JP2015518818A5 (enExample)
RU2600440C3 (ru) Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты
HRP20181026T1 (hr) Dugodjelujuće formulacije inzulina
JP2013520405A5 (enExample)
JP2016519128A5 (enExample)
WO2015184256A3 (en) Biodegradable lipids for delivery of nucleic acids
JP2016531901A5 (enExample)
JP2014515356A5 (enExample)
JP2011241213A5 (enExample)
JP2015527402A5 (enExample)
JP2016534153A5 (enExample)
FI3229828T3 (fi) Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio
DOP2017000294A (es) Unidad de dosificación orodispersable que contiene un componente estetrol
SG195258A1 (en) Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
JP2016512248A5 (enExample)
JP2010522698A5 (enExample)
JP2010521420A5 (enExample)
JP2013534227A5 (enExample)
JP2012529293A5 (enExample)
JP2014218522A5 (enExample)
IN2014DN06920A (enExample)
WO2014006502A8 (en) Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery
JP2018504450A5 (enExample)
WO2011013032A3 (en) Method for the preparation of microparticles with efficient bioactive molecule incorporation